160 related articles for article (PubMed ID: 37052722)
1. Liver transplantation and hepatocellular carcinoma: is TIPS deleterious? A multicentric retrospective study of the ARCHET research group with propensity score matching.
Laurent C; Rayar M; Maulat C; Muscari F; Marichez A; Gregoire E; Chopinet S; Mabrut JY; Boudjema K; Lesurtel M; Adam JP; Mohkam K; Chiche L
Langenbecks Arch Surg; 2023 Apr; 408(1):149. PubMed ID: 37052722
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
3. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with hepatocellular carcinoma meeting the Milan criteria.
Luo J; Li M; Wu C; Zhu D; Wang H; Huang M; Jiang Z
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):436-442. PubMed ID: 32398493
[TBL] [Abstract][Full Text] [Related]
5. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
[TBL] [Abstract][Full Text] [Related]
6. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
[TBL] [Abstract][Full Text] [Related]
8. Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation.
Goldaracena N; Mehta N; Scalera I; Sposito C; Atenafu EG; Yao FY; Muiesan P; Mazzaferro V; Sapisochin G
HPB (Oxford); 2019 Jun; 21(6):731-738. PubMed ID: 30391218
[TBL] [Abstract][Full Text] [Related]
9. Blood Cell Salvage and Autotransfusion Does Not Worsen Oncologic Outcomes Following Liver Transplantation with Incidental Hepatocellular Carcinoma: A Propensity Score-Matched Analysis.
Ivanics T; Shubert CR; Muaddi H; Claasen MPAW; Yoon P; Hansen BE; McCluskey SA; Sapisochin G
Ann Surg Oncol; 2021 Oct; 28(11):6816-6825. PubMed ID: 33778907
[TBL] [Abstract][Full Text] [Related]
10. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
11. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
12. Direct-Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait-List Progression or Posttransplant Recurrence.
Piñero F; Boin I; Chagas A; Quiñonez E; Marciano S; Vilatobá M; Santos L; Anders M; Hoyos Duque S; Soares Lima A; Menendez J; Padilla M; Poniachik J; Zapata R; Maraschio M; Chong Menéndez R; Muñoz L; Arufe D; Figueroa R; Mendizabal M; Hurtado Gomez S; Stucchi R; Maccali C; Vergara Sandoval R; Bermudez C; McCormack L; Varón A; Gadano A; Mattera J; Rubinstein F; Carrilho F; Silva M
Liver Transpl; 2020 May; 26(5):640-650. PubMed ID: 32133773
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
14. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
[TBL] [Abstract][Full Text] [Related]
16. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
[TBL] [Abstract][Full Text] [Related]
18. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.
Han S; Lee S; Yang JD; Leise MD; Ahn JH; Kim S; Jung K; Gwak MS; Kim GS; Ko JS
Liver Transpl; 2018 Jan; 24(1):44-55. PubMed ID: 29024412
[TBL] [Abstract][Full Text] [Related]
19. Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients.
Krumeich LN; Mancinelli J; Cucchiara A; Eddinger K; Aufhauser D; Goldberg DW; Siegelman ES; Rosen M; Reddy KR; Hoteit M; Furth EE; Olthoff KM; Shaked A; Levine M; Abt P
Liver Transpl; 2021 Sep; 27(9):1248-1261. PubMed ID: 33853207
[TBL] [Abstract][Full Text] [Related]
20. Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3 cm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis.
Wong LL; Landsittel DP; Kwee SA
J Am Coll Surg; 2023 Sep; 237(3):568-577. PubMed ID: 37102575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
